pharma · Narcolepsy and Idiopathic Hypersomnia · Narcolepsy Type 1 · CNTA
Centessa Pharmaceuticals
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals is a pharma organization headquartered in Cheshire, GB. It trades on NYSE under ticker CNTA. Primary therapeutic focus areas include Narcolepsy and Idiopathic Hypersomnia, Narcolepsy Type 1, Adva
1 Ashley Road, Cheshire, WA14 2DT, United Kingdom, GB HQ
2021 Founded
142 Employees
Public company Type
CNTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1 Ashley Road, Cheshire, WA14 2DT, United Kingdom, GB
- Founded
- 2021
- Employees
- 142
- Programs
- 15
- Drugs
- 11
- Patents
- 7
cleminorexton
Phase 3 · small molecule · Narcolepsy Type 1
cleminorexton for Narcolepsy Type 1 is a Phase 3 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Internal code ORX750-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Centessa Pharmaceuticals plc
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Narcolepsy Type 1
- Status
- active
- Trials
- 1